PCN32 COST-UTILITY ANALYSIS OF DOCETAXEL VERSUS OTHER REGIMENS IN THE NEOADJUVANT THERAPY OF LOCALLY ADVANCED BREAST CANCER IN POLAND
May 1, 2007, 00:00
10.1016/S1098-3015(10)68942-5
https://www.valueinhealthjournal.com/article/S1098-3015(10)68942-5/fulltext
Title :
PCN32 COST-UTILITY ANALYSIS OF DOCETAXEL VERSUS OTHER REGIMENS IN THE NEOADJUVANT THERAPY OF LOCALLY ADVANCED BREAST CANCER IN POLAND
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)68942-5&doi=10.1016/S1098-3015(10)68942-5
First page :
Section Title :
Open access? :
No
Section Order :
124